Scott W. Baumgartner is a rheumatologist and clinical researcher with extensive experience leading clinical trials and medical affairs functions at pharmaceutical companies. He has held roles such as Vice President of Medical Affairs and Clinical Research & Development at Ardea Biosciences and Amgen, where he oversaw global clinical development programs and medical evidence generation activities. Currently, he works as an independent consultant providing advice to pharmaceutical companies on various healthcare issues.
This document provides a final report on a project to develop and evaluate an emergency medicine resident training curriculum focused on interpersonal and professionalism skills. The project aimed to:
1) Design, implement, and evaluate a patient-centered healthcare curriculum for 60 emergency medicine residents.
2) Evaluate the predictive validity of objective structured clinical examinations (OSCEs) by assessing resident performance on OSCEs and in actual patient care.
3) Disseminate the patient-centered care educational program to other emergency medicine programs.
The project was conducted in four phases: establishing a baseline with OSCEs, developing and implementing interactive workshop curriculum, conducting post-curriculum OSCEs, and piloting un
This document discusses rehabilitation clinical documentation. It emphasizes the importance of using valid and reliable outcome measures to assess patients and determine functional goals and progress. Goals should be based on impairments identified through objective tests and linked to functional limitations. Proper documentation requires justifying medical necessity through measurable changes in function from the patient's perspective.
Pejman Ferdowsian is a medical doctor seeking a new position. He has over 10 years of experience in various medical specialties including family medicine, internal medicine, surgery, obstetrics/gynecology, pathology, pediatrics, psychiatry, and interventional radiology. He has worked in clinical settings in the US and Canada. Pejman has strong communication, research, and analysis skills. He is currently involved in ongoing medical research and professional development.
An overview of HEALTH & Financial forecasting in hospitals By Dr.Mahboob Khan...Healthcare consultant
This document provides an overview of health forecasting. It defines health forecasting as predicting future health events or situations to facilitate preventative healthcare and resource planning. The document outlines some key principles of health forecasting, including measuring uncertainty, focusing on aggregated population data for improved accuracy, and defining appropriate forecasting horizons. It also discusses challenges like data limitations and demonstrating forecast performance. Overall, the document aims to stimulate discussion on standardizing approaches to health forecasting to better support healthcare delivery and services.
Lisa M. Golightly is a physical therapist with over 8 years of experience working in private practices, home health, and skilled nursing facilities. She has treated patients across the lifespan from pediatrics to geriatrics for various conditions using therapeutic exercises, manual therapy, and modalities. Golightly holds several credentials including her DPT, certifications in athletic training, strength and conditioning, and kinesio taping. She is currently the head PT and clinic manager at Therapy PROS in Menifee, CA where she oversees staff and manages all aspects of patient care.
Medical interdisciplinary fields alan moelleken md lawsuit anti trust suit-mdAlan Moelleken
These documents are for inquiry into medical terms. They are basic and do not represent the expanding knowledge of medical terms, anti-trust, jury lawsuits, trial cases and legal and medical case law in courts.
Evidence based practice for managing hypertension solution.editedIsaiah Ogutu
This document discusses evidence-based practice for managing hypertension. It notes that hypertension is a significant health issue affecting millions in the US and globally. An evidence-based model for management involves accurate and repeated blood pressure measurements taken by various healthcare providers to ensure the right diagnosis and treatment. Quality improvement models also aim to better control blood pressure through strategies like standardized measurement techniques and simplified medication regimens to improve patient adherence. Team-based care and collaboration across the healthcare system are important for effective hypertension management.
This document contains the resume of Ahmed Mustafa Ali Younes. It summarizes his educational and professional qualifications. He received his Bachelor of Medicine and Surgery degree from Tanta University in Egypt in 2014. His clinical experience includes internships in various medical departments in Tanta University Hospitals. He has worked as a general practitioner and currently works as a research assistant conducting next generation sequencing.
This document provides a final report on a project to develop and evaluate an emergency medicine resident training curriculum focused on interpersonal and professionalism skills. The project aimed to:
1) Design, implement, and evaluate a patient-centered healthcare curriculum for 60 emergency medicine residents.
2) Evaluate the predictive validity of objective structured clinical examinations (OSCEs) by assessing resident performance on OSCEs and in actual patient care.
3) Disseminate the patient-centered care educational program to other emergency medicine programs.
The project was conducted in four phases: establishing a baseline with OSCEs, developing and implementing interactive workshop curriculum, conducting post-curriculum OSCEs, and piloting un
This document discusses rehabilitation clinical documentation. It emphasizes the importance of using valid and reliable outcome measures to assess patients and determine functional goals and progress. Goals should be based on impairments identified through objective tests and linked to functional limitations. Proper documentation requires justifying medical necessity through measurable changes in function from the patient's perspective.
Pejman Ferdowsian is a medical doctor seeking a new position. He has over 10 years of experience in various medical specialties including family medicine, internal medicine, surgery, obstetrics/gynecology, pathology, pediatrics, psychiatry, and interventional radiology. He has worked in clinical settings in the US and Canada. Pejman has strong communication, research, and analysis skills. He is currently involved in ongoing medical research and professional development.
An overview of HEALTH & Financial forecasting in hospitals By Dr.Mahboob Khan...Healthcare consultant
This document provides an overview of health forecasting. It defines health forecasting as predicting future health events or situations to facilitate preventative healthcare and resource planning. The document outlines some key principles of health forecasting, including measuring uncertainty, focusing on aggregated population data for improved accuracy, and defining appropriate forecasting horizons. It also discusses challenges like data limitations and demonstrating forecast performance. Overall, the document aims to stimulate discussion on standardizing approaches to health forecasting to better support healthcare delivery and services.
Lisa M. Golightly is a physical therapist with over 8 years of experience working in private practices, home health, and skilled nursing facilities. She has treated patients across the lifespan from pediatrics to geriatrics for various conditions using therapeutic exercises, manual therapy, and modalities. Golightly holds several credentials including her DPT, certifications in athletic training, strength and conditioning, and kinesio taping. She is currently the head PT and clinic manager at Therapy PROS in Menifee, CA where she oversees staff and manages all aspects of patient care.
Medical interdisciplinary fields alan moelleken md lawsuit anti trust suit-mdAlan Moelleken
These documents are for inquiry into medical terms. They are basic and do not represent the expanding knowledge of medical terms, anti-trust, jury lawsuits, trial cases and legal and medical case law in courts.
Evidence based practice for managing hypertension solution.editedIsaiah Ogutu
This document discusses evidence-based practice for managing hypertension. It notes that hypertension is a significant health issue affecting millions in the US and globally. An evidence-based model for management involves accurate and repeated blood pressure measurements taken by various healthcare providers to ensure the right diagnosis and treatment. Quality improvement models also aim to better control blood pressure through strategies like standardized measurement techniques and simplified medication regimens to improve patient adherence. Team-based care and collaboration across the healthcare system are important for effective hypertension management.
This document contains the resume of Ahmed Mustafa Ali Younes. It summarizes his educational and professional qualifications. He received his Bachelor of Medicine and Surgery degree from Tanta University in Egypt in 2014. His clinical experience includes internships in various medical departments in Tanta University Hospitals. He has worked as a general practitioner and currently works as a research assistant conducting next generation sequencing.
The annual report summarizes the accomplishments of the Department of Emergency Medicine from July 1, 2014 to June 30, 2015. It highlights increased faculty and resident numbers, the opening of a new emergency department, and expanded research, education, and clinical programs. It provides details on faculty awards, publications, grants, and leadership roles both within the department and for professional organizations. The report demonstrates the significant growth and achievements of the department during the past academic year.
An expert discusses strategies for implementing a good academic emergency medicine training program. Key aspects include:
- Strong selection process and induction training to prepare students.
- Focused clinical rotations, electives, life support courses, procedures, and skills training to build proficiency.
- Daily teaching, case discussions, bedside learning and faculty coverage to mentor students.
- Evaluations, research, workshops and conferences to assess progress and support continued learning.
- Exit exams to ensure students have achieved expected competencies before completing the program.
The document provides a summary and detailed outline of the topics and weighting that may be covered on the Certified Patient Care Technician/Assistant (CPCT/A) certification exam. The 100 item exam is divided into 5 domains: Patient Care (45 items), Compliance, Safety, and Professional Responsibility (20 items), Infection Control (11 items), Phlebotomy (14 items), and EKG (10 items). The detailed outline lists the tasks and knowledge statements in each domain that candidates should know to properly perform the duties of a CPCT/A.
This document provides an overview of the Med-Peds specialty, which involves training and practice in both internal medicine and pediatrics. It discusses the history and development of Med-Peds programs, the residency and training process, practice options, growth potential, and salaries for Med-Peds physicians. The document also examines reasons for choosing Med-Peds and provides results from an O-Net profiler assessment of the author's investigative and social skills that relate to this specialty.
Megan McLelland is a physician who focuses on primary care and manual medicine. She has a holistic outlook influenced by Dr. Andrew Taylor Still, the founder of osteopathic medicine in 1892. Dr. Still opened the first osteopathic school in Missouri after studying alternative treatments and believing orthodox medicine was ineffective. Osteopathic medicine focuses on how the musculoskeletal system impacts health and uses osteopathic manipulative medicine to improve the body's functioning and ability to heal. Today, the majority of osteopathic physicians specialize in family/general practice, and while differences between DOs and MDs exist, their roles are becoming increasingly similar with both licensed in all 50 states.
The document provides a summary of Fahd Abdel-Azim Hassan Abdel-Galil's clinical experience and qualifications as a physical therapist. It details his 14 years of experience working in physical therapy positions in Saudi Arabia and Egypt, treating patients and managing physical therapy departments. It also lists his education credentials, including a Master's degree in Physical Therapy from Cairo University, and certifications in various physical therapy techniques.
This document discusses the role of nurse practitioners in healthcare. It begins by defining advanced practice nurses, which includes nurse practitioners, clinical nurse specialists, certified nurse midwives, and certified nurse anesthetists. It then provides statistics on the number of each type of advanced practice nurse. The history and development of the nurse practitioner role is summarized, noting their increasing independence and scope of practice similar to primary care physicians. Outcomes research is highlighted showing nurse practitioners can effectively treat most patients and have equal or better health outcomes compared to physicians.
This document provides summaries of several medical textbooks and references that were published or republished in August-September 2005. It includes summaries of two editions of Goodman & Gilman's The Pharmacological Basis of Therapeutics, known as the leading textbook in pharmacology. It also summarizes editions of books on nursing, internal medicine, cardiology, emergency medicine, and other topics. For each book, it lists the authors, publisher, price, and other publication details. The document appears to be a sales catalogue or informational release from a medical publisher announcing new and updated titles.
This document provides the curriculum vitae of Dr. Peter J. Molinaro, including his education, postdoctoral training, hospital and academic appointments, certifications, honors, professional organizations, publications, and other employment. It details that he received his MD from NYU School of Medicine in 1987 and his MPH in Global Health Leadership from NYU's Global Institute of Public Health in 2015. He has held positions as an attending physician in cardiothoracic surgery and has been licensed to practice medicine in New York, Michigan, and Connecticut.
This document discusses the importance of proper medical documentation. It begins by defining medical documentation and outlining its key purposes, which include preserving patient information, justifying treatment, allowing for continuity of care, and satisfying regulatory requirements. The document emphasizes that documentation must be accurate, complete, legible, objective, and free of extraneous information. It differentiates between objective clinical findings and subjective patient-reported information. Proper documentation is presented as important for patient care, risk management, and legal protection for medical professionals.
ASHICE is a mnemonic acronym used by emergency personnel to efficiently communicate key details about a patient's condition when transferring them to another medical facility by radio. It stands for Age, Sex, History, Injuries/Illness, Condition, and Estimated Time of Arrival. IMIST-AMBO is a standardized handover protocol for transferring patient information from emergency medical technicians and paramedics to emergency department clinicians during patient handoff. It includes identifying the patient, describing the mechanism/medical complaint, injuries/information, signs, treatment and trends, allergies, medications, background history, and other relevant information. Maintaining a 20-30 second uninterrupted period for the initial details and encouraging questions ensures
International joint project_for_socra_20 (2)Ufuk Yurdalan
The document discusses the requirements for obtaining informed consent from patients participating in clinical drug trials versus physical intervention trials. It finds that while the standards for drug trials outlined in ICH GCP are well established, requirements for physical therapy trials are less clear. Through a literature review, it identifies guidelines from the World Confederation for Physical Therapy and the Chartered Society of Physiotherapy in the UK. Many elements of informed consent are comparable between drug and physical therapy trials, including defining consent, why it is needed, who obtains it, and special populations. However, fewer topics are required for discussion in physical therapy consent compared to drug trials based on ICH GCP.
This document describes a model of orthopaedic dysfunction that can be used as a clinical decision-making framework in physical therapy. The model outlines how various stimuli can lead to internal tissue responses, impairments, functional disabilities, and handicaps. It presents the internal tissue response section in detail to help therapists analyze patients' impairments in relation to the pathophysiology. The model is intended to help therapists formulate hypotheses about dysfunction, explain examination and treatment choices, and identify appropriate treatment goals. A case study is used to demonstrate how the model can be applied in clinical practice. The document also discusses implications for using the model in education and research.
The document summarizes plans for renewing the curriculum at a medical school. It will transition from the current curriculum organized around years 1-4 to a new competency-based model with four main elements: Science in Medicine, Clinical Medicine, Health & Society, and Professional Development. The renewal will be implemented in three phases over several years through extensive faculty development and input from various committees to develop the new organization, content, instructional design, and assessment tools.
This document provides an introduction to a review article about the clinical approach to diagnosing movement disorders. It discusses the prevalence of common movement disorders like Parkinson's disease and essential tremor. The key to diagnosis is accurately classifying the type of movement disorder present based on the clinical presentation. This involves defining the dominant abnormal movement as well as any associated neurological or non-neurological features. Once classified, the movement disorder can guide further diagnostic testing and help establish a differential diagnosis. The review will cover approaches to diagnosing akinetic-rigid syndromes and hyperkinetic disorders like tics, chorea, dystonia and tremor.
The document outlines the third year B.Sc nursing curriculum for medical surgical nursing, including the organization of critical care units, emergency and disaster care, care of the elderly, respiratory disorders, cardiac conditions, neurological conditions, renal disorders, oncology, plastic surgery, and includes details on theory, practical training, course objectives, content, teaching methods and assessment. Students will develop skills in critical care, emergency response, care of patients with various medical conditions, and counseling through classroom and clinical experience. The curriculum aims to enable students to provide comprehensive nursing care using the nursing process approach for complex medical and surgical patients.
The declaration of helsinki by akshdeep sharmaAkshdeep Sharma
This document summarizes the Declaration of Helsinki, which outlines ethical principles for medical research involving human subjects. It was originally adopted in 1964 and has been amended multiple times, most recently in 2013. The declaration addresses the duties of physicians to protect research participants and ensure their well-being and rights. It also discusses informed consent, risk/benefit assessments, vulnerable groups, and compensation in case of injury. The overall purpose is to promote ethical research that respects the health, dignity and self-determination of all human subjects.
A DO is a physician who receives a Doctor of Osteopathic Medicine degree and emphasizes a holistic approach to medicine, including osteopathic manipulative medicine. The first DO school was founded in 1892 by Dr. Andrew Taylor Still, who believed orthodox medicine was ineffective. Today, DOs are licensed to practice in all 50 U.S. states and focus on primary care more than other specialties. While the differences between DOs and MDs have lessened over time, DOs still place greater emphasis on preventative health and treating the whole patient. Becoming a DO requires an undergraduate degree with prerequisite courses, the MCAT, and graduation from an accredited osteopathic medical school.
The document provides information about the M.D. curriculum and student experience at Stanford University School of Medicine. It outlines the core aspects and objectives of the curriculum, which spans four years and includes foundational courses in the first year before progressing to clinical clerkships. Students have opportunities to gain patient care experience at major medical facilities affiliated with Stanford including Stanford Hospital. The school provides strong academic and personal support to students through dedicated advisors, funding opportunities, and cultivating a collaborative learning environment. Alumni praise Stanford for its leadership in medical education reform and for developing confident physicians through a well-rounded educational experience.
Los edublogs son blogs que se usan con fines educativos por profesores, maestros y alumnos para apoyar el proceso de enseñanza-aprendizaje. Ofrecen flexibilidad en plazos y estilos, actualización constante, y construcción colaborativa de conocimiento. Existen diferentes tipos como blogs de aula, blogs personales de alumnos, talleres creativos, gestión de proyectos de grupo y publicaciones electrónicas. Se pueden usar como herramienta de comunicación, foro de discusión, mejora de la redacción,
The annual report summarizes the accomplishments of the Department of Emergency Medicine from July 1, 2014 to June 30, 2015. It highlights increased faculty and resident numbers, the opening of a new emergency department, and expanded research, education, and clinical programs. It provides details on faculty awards, publications, grants, and leadership roles both within the department and for professional organizations. The report demonstrates the significant growth and achievements of the department during the past academic year.
An expert discusses strategies for implementing a good academic emergency medicine training program. Key aspects include:
- Strong selection process and induction training to prepare students.
- Focused clinical rotations, electives, life support courses, procedures, and skills training to build proficiency.
- Daily teaching, case discussions, bedside learning and faculty coverage to mentor students.
- Evaluations, research, workshops and conferences to assess progress and support continued learning.
- Exit exams to ensure students have achieved expected competencies before completing the program.
The document provides a summary and detailed outline of the topics and weighting that may be covered on the Certified Patient Care Technician/Assistant (CPCT/A) certification exam. The 100 item exam is divided into 5 domains: Patient Care (45 items), Compliance, Safety, and Professional Responsibility (20 items), Infection Control (11 items), Phlebotomy (14 items), and EKG (10 items). The detailed outline lists the tasks and knowledge statements in each domain that candidates should know to properly perform the duties of a CPCT/A.
This document provides an overview of the Med-Peds specialty, which involves training and practice in both internal medicine and pediatrics. It discusses the history and development of Med-Peds programs, the residency and training process, practice options, growth potential, and salaries for Med-Peds physicians. The document also examines reasons for choosing Med-Peds and provides results from an O-Net profiler assessment of the author's investigative and social skills that relate to this specialty.
Megan McLelland is a physician who focuses on primary care and manual medicine. She has a holistic outlook influenced by Dr. Andrew Taylor Still, the founder of osteopathic medicine in 1892. Dr. Still opened the first osteopathic school in Missouri after studying alternative treatments and believing orthodox medicine was ineffective. Osteopathic medicine focuses on how the musculoskeletal system impacts health and uses osteopathic manipulative medicine to improve the body's functioning and ability to heal. Today, the majority of osteopathic physicians specialize in family/general practice, and while differences between DOs and MDs exist, their roles are becoming increasingly similar with both licensed in all 50 states.
The document provides a summary of Fahd Abdel-Azim Hassan Abdel-Galil's clinical experience and qualifications as a physical therapist. It details his 14 years of experience working in physical therapy positions in Saudi Arabia and Egypt, treating patients and managing physical therapy departments. It also lists his education credentials, including a Master's degree in Physical Therapy from Cairo University, and certifications in various physical therapy techniques.
This document discusses the role of nurse practitioners in healthcare. It begins by defining advanced practice nurses, which includes nurse practitioners, clinical nurse specialists, certified nurse midwives, and certified nurse anesthetists. It then provides statistics on the number of each type of advanced practice nurse. The history and development of the nurse practitioner role is summarized, noting their increasing independence and scope of practice similar to primary care physicians. Outcomes research is highlighted showing nurse practitioners can effectively treat most patients and have equal or better health outcomes compared to physicians.
This document provides summaries of several medical textbooks and references that were published or republished in August-September 2005. It includes summaries of two editions of Goodman & Gilman's The Pharmacological Basis of Therapeutics, known as the leading textbook in pharmacology. It also summarizes editions of books on nursing, internal medicine, cardiology, emergency medicine, and other topics. For each book, it lists the authors, publisher, price, and other publication details. The document appears to be a sales catalogue or informational release from a medical publisher announcing new and updated titles.
This document provides the curriculum vitae of Dr. Peter J. Molinaro, including his education, postdoctoral training, hospital and academic appointments, certifications, honors, professional organizations, publications, and other employment. It details that he received his MD from NYU School of Medicine in 1987 and his MPH in Global Health Leadership from NYU's Global Institute of Public Health in 2015. He has held positions as an attending physician in cardiothoracic surgery and has been licensed to practice medicine in New York, Michigan, and Connecticut.
This document discusses the importance of proper medical documentation. It begins by defining medical documentation and outlining its key purposes, which include preserving patient information, justifying treatment, allowing for continuity of care, and satisfying regulatory requirements. The document emphasizes that documentation must be accurate, complete, legible, objective, and free of extraneous information. It differentiates between objective clinical findings and subjective patient-reported information. Proper documentation is presented as important for patient care, risk management, and legal protection for medical professionals.
ASHICE is a mnemonic acronym used by emergency personnel to efficiently communicate key details about a patient's condition when transferring them to another medical facility by radio. It stands for Age, Sex, History, Injuries/Illness, Condition, and Estimated Time of Arrival. IMIST-AMBO is a standardized handover protocol for transferring patient information from emergency medical technicians and paramedics to emergency department clinicians during patient handoff. It includes identifying the patient, describing the mechanism/medical complaint, injuries/information, signs, treatment and trends, allergies, medications, background history, and other relevant information. Maintaining a 20-30 second uninterrupted period for the initial details and encouraging questions ensures
International joint project_for_socra_20 (2)Ufuk Yurdalan
The document discusses the requirements for obtaining informed consent from patients participating in clinical drug trials versus physical intervention trials. It finds that while the standards for drug trials outlined in ICH GCP are well established, requirements for physical therapy trials are less clear. Through a literature review, it identifies guidelines from the World Confederation for Physical Therapy and the Chartered Society of Physiotherapy in the UK. Many elements of informed consent are comparable between drug and physical therapy trials, including defining consent, why it is needed, who obtains it, and special populations. However, fewer topics are required for discussion in physical therapy consent compared to drug trials based on ICH GCP.
This document describes a model of orthopaedic dysfunction that can be used as a clinical decision-making framework in physical therapy. The model outlines how various stimuli can lead to internal tissue responses, impairments, functional disabilities, and handicaps. It presents the internal tissue response section in detail to help therapists analyze patients' impairments in relation to the pathophysiology. The model is intended to help therapists formulate hypotheses about dysfunction, explain examination and treatment choices, and identify appropriate treatment goals. A case study is used to demonstrate how the model can be applied in clinical practice. The document also discusses implications for using the model in education and research.
The document summarizes plans for renewing the curriculum at a medical school. It will transition from the current curriculum organized around years 1-4 to a new competency-based model with four main elements: Science in Medicine, Clinical Medicine, Health & Society, and Professional Development. The renewal will be implemented in three phases over several years through extensive faculty development and input from various committees to develop the new organization, content, instructional design, and assessment tools.
This document provides an introduction to a review article about the clinical approach to diagnosing movement disorders. It discusses the prevalence of common movement disorders like Parkinson's disease and essential tremor. The key to diagnosis is accurately classifying the type of movement disorder present based on the clinical presentation. This involves defining the dominant abnormal movement as well as any associated neurological or non-neurological features. Once classified, the movement disorder can guide further diagnostic testing and help establish a differential diagnosis. The review will cover approaches to diagnosing akinetic-rigid syndromes and hyperkinetic disorders like tics, chorea, dystonia and tremor.
The document outlines the third year B.Sc nursing curriculum for medical surgical nursing, including the organization of critical care units, emergency and disaster care, care of the elderly, respiratory disorders, cardiac conditions, neurological conditions, renal disorders, oncology, plastic surgery, and includes details on theory, practical training, course objectives, content, teaching methods and assessment. Students will develop skills in critical care, emergency response, care of patients with various medical conditions, and counseling through classroom and clinical experience. The curriculum aims to enable students to provide comprehensive nursing care using the nursing process approach for complex medical and surgical patients.
The declaration of helsinki by akshdeep sharmaAkshdeep Sharma
This document summarizes the Declaration of Helsinki, which outlines ethical principles for medical research involving human subjects. It was originally adopted in 1964 and has been amended multiple times, most recently in 2013. The declaration addresses the duties of physicians to protect research participants and ensure their well-being and rights. It also discusses informed consent, risk/benefit assessments, vulnerable groups, and compensation in case of injury. The overall purpose is to promote ethical research that respects the health, dignity and self-determination of all human subjects.
A DO is a physician who receives a Doctor of Osteopathic Medicine degree and emphasizes a holistic approach to medicine, including osteopathic manipulative medicine. The first DO school was founded in 1892 by Dr. Andrew Taylor Still, who believed orthodox medicine was ineffective. Today, DOs are licensed to practice in all 50 U.S. states and focus on primary care more than other specialties. While the differences between DOs and MDs have lessened over time, DOs still place greater emphasis on preventative health and treating the whole patient. Becoming a DO requires an undergraduate degree with prerequisite courses, the MCAT, and graduation from an accredited osteopathic medical school.
The document provides information about the M.D. curriculum and student experience at Stanford University School of Medicine. It outlines the core aspects and objectives of the curriculum, which spans four years and includes foundational courses in the first year before progressing to clinical clerkships. Students have opportunities to gain patient care experience at major medical facilities affiliated with Stanford including Stanford Hospital. The school provides strong academic and personal support to students through dedicated advisors, funding opportunities, and cultivating a collaborative learning environment. Alumni praise Stanford for its leadership in medical education reform and for developing confident physicians through a well-rounded educational experience.
Los edublogs son blogs que se usan con fines educativos por profesores, maestros y alumnos para apoyar el proceso de enseñanza-aprendizaje. Ofrecen flexibilidad en plazos y estilos, actualización constante, y construcción colaborativa de conocimiento. Existen diferentes tipos como blogs de aula, blogs personales de alumnos, talleres creativos, gestión de proyectos de grupo y publicaciones electrónicas. Se pueden usar como herramienta de comunicación, foro de discusión, mejora de la redacción,
Este documento presenta dos esquemas de tesis para estudiantes de posgrado. El primer esquema incluye capítulos sobre el problema de investigación, marco teórico y metodología. El segundo esquema se enfoca en la propuesta tecnológica, e incluye capítulos sobre la fundamentación, características y evaluación de la nueva tecnología propuesta, así como la metodología. Ambos esquemas concluyen con resultados, discusiones y recomendaciones. Además, se presentan tres fichas para la
Esta actividad pretende mostrar una tendencia y enfoque innovador, el aprendizaje invertido desarrollado en mi clase de ciencias sociales del grado octavo en la Institución Francisco de Paula Santander. IbaguèTolima
Este documento presenta los términos de la garantía limitada estándar de 3 años de Toshiba para accesorios de computadora y productos electrónicos. La garantía cubre defectos en materiales y mano de obra, y proporciona reemplazo o reembolso como único recurso si falla el producto. No cubre daños, uso indebido, software, accesorios, o aplicaciones críticas.
1.1.1 f notulen penyusunan perencanaan puskesmasHerti Septiani
Rapat miniloka tahunan Puskesmas Baros membahas rencana program kesehatan tahun 2015, meliputi promosi kesehatan, lingkungan, KIA/KB, gizi, penyakit menular, sekolah, gigi dan mulut, haji, jiwa, serta manajemen puskesmas. Rapat dihadiri 42 peserta dan membahas evaluasi tahun lalu, petunjuk penyusunan rencana, serta target prioritas setiap program kesehatan.
This document discusses different types of linking words that can be used to connect ideas and sentences when speaking or writing in English. It provides examples of linking words that can be used to sequence information, give results, emphasize points, add additional information, give reasons, provide examples, contrast ideas, and make comparisons. Specific linking words are listed under each category to illustrate how they can be used.
La empresa Garden Sport se dedica a la conservación de la flora local mediante investigación científica, transferencia tecnológica y educación ambiental. Su visión es ser reconocida internacionalmente en 2017 como centro de investigación que aplica resultados para beneficio social y aumentar la capacidad de la población para usar de manera sostenible la diversidad vegetal. Sus objetivos incluyen crear ambientes verdes en hogares para compartir en familia y armonizar los espacios verdes dentro del hogar.
This document provides an algebra lesson on solving systems of inequalities by graphing. It includes examples of writing systems of inequalities to model real-world scenarios, graphing the corresponding lines or regions, and determining the solution set as the region where all inequalities are satisfied. The key steps are to graph each inequality individually, determine the side containing solutions, then identify the overlap region as satisfying the entire system.
El documento describe el desarrollo del periodismo digital. En 1945, Vannevar diseñó el memex, una máquina precursora del periodismo digital. En 1992, el Chicago Tribune publicó el primer periódico en internet aunque inicialmente solo subía su versión impresa. En 1994, el periódico español El Temps fue pionero en actualizar noticias constantemente en su versión digital. Este modelo se extendió a otros medios españoles y mexicanos a principios de los 2000.
This document summarizes the professional experience of an individual with over 20 years in clinical research and medical affairs in the respiratory field. Some key points:
- Current role as Scientific Director of Respiratory Medicine Development at GlaxoSmithKline since 2001, leading clinical development programs and regulatory submissions.
- Previous roles included clinical program head and principal clinical research scientist at Glaxo Wellcome from 1994-2001, managing phase IV clinical trials and supporting product launches.
- Extensive experience in areas such as asthma, COPD, clinical trials, regulatory submissions, publications, and medical education.
- Demonstrated strong communication, project management, and cross-functional skills over long career in drug development and commercial
This document is the curriculum vitae of Julia Balfour, outlining her experience and qualifications as a medical writer and editor based in the UK. She has over 20 years of experience in medical writing for medical publishers, pharmaceutical companies, and as a freelancer. She has authored over 50 publications and provides editorial support and manuscript writing services for research teams. Her areas of expertise include oncology, hematology, nephrology, and health economics.
A Catalyst For Transforming Health Systems And Person-Centred Care Canadian ...Becky Gilbert
This document presents a Canadian national position statement on patient-reported outcomes (PROs) from a steering committee of PRO experts.
The key points are:
1. PROs capture the patient perspective on health and quality of life and can improve care, but their use is not consistent in Canada. This position statement aims to support greater PRO implementation.
2. The position statement was developed through an expert consensus process and stakeholder feedback. It contains recommendations in 4 areas: patients and families, health policy, clinical implementation, and research.
3. The overarching recommendations are that resources should be invested to integrate PROs into care, a national PRO body is needed for guidance, and PRO tools must
Outcomes research examines the end results of healthcare provided to patients and uses this information to provide scientific evidence to help clinicians and patients make informed healthcare decisions. It aims to include subjective patient-reported outcomes like quality of life that were previously excluded from traditional clinical research. Two key organizations that conduct outcomes research are the Patient-Centered Outcomes Research Institute (PCORI), which funds research to help patients make healthcare choices based on desired outcomes, and the Agency for Healthcare Research and Quality (AHRQ), which develops knowledge and measures to improve patient safety and healthcare quality. While outcomes research provides important patient-centered data, limitations include potential reluctance to share private information and variability in how patients perceive symptoms and treatment impact.
Digestive system part 3 liver etc 2nd editionmostafa hegazy
This document provides information about the editors and contributors of "The Netter Collection of Medical Illustrations Digestive System: Part III—Liver, Biliary Tract, and Pancreas, Volume 9, Second Edition". It lists the editors, their backgrounds and areas of expertise. It also provides brief biographies of some of the contributing illustrators and acknowledges the publishing team.
This document provides biographical and professional information about Richard L. McKnight, Pharm.D. It includes his contact information, education history, professional experience since 1999 as a critical care clinical specialist at West Virginia University Hospitals, publications, presentations, and committee/protocol work primarily related to critical care pharmacy.
This document provides a summary of John Paul Hickey's professional experience and qualifications. He is a physician with a master's in public health who currently works at Gilead Sciences discussing their HIV and hepatitis C treatment products. Previously he has worked in clinical roles treating patients with HIV, hepatitis C, and addiction. He has over 10 years of experience in the biopharmaceutical industry establishing relationships with key opinion leaders and presenting clinical data.
Module 4 Submodule 4. 2 Final June 2007Flavio Guzmán
The document discusses key considerations for clinicians in evaluating the results of drug clinical trials. It emphasizes the importance of critically assessing trial design, results, and whether the findings warrant changing clinical practice. Clinicians are advised to consider factors like trial methodology, potential biases, statistical/clinical significance, applicability to their patients, and safety. The document provides guidance on how to distinguish high-quality trials that produce useful results for patient care.
Peter Blaisdell has over 30 years of experience in clinical research and drug development. He holds a Ph.D. in Biochemistry from the University of Minnesota and currently serves on the boards of two organizations, providing scientific and business advice. Throughout his career, he has held various leadership roles at Amgen and Quintiles, overseeing clinical studies in multiple therapeutic areas. He has authored and co-authored numerous publications and presentations on topics related to clinical research and drug development.
This multi-year study analyzed end-of-life discussions at a cancer center over four years. On average, 113 patients expired each year, with 60 expiring seven or more days after admission. Lung cancer was the most common cause of death. While palliative care consultations occurred for only 25.5% of patients on average, the study found no correlations between variables like timing of discussions, location, attendance, and palliative care involvement. Without interventions between years, the study could not measure performance improvement directly. Future research would require implementing interventions to gauge their impact over multiple years.
Running Head PICOT STATEMENT ON PRESSURE ULCERS1PICOT STA.docxgemaherd
Running Head: PICOT STATEMENT ON PRESSURE ULCERS
1
PICOT STATEMENT ON PRESSURE ULCERS
2
PICOT Question pressure ulcers
Student’s Name: Vladimir Andino
University Affiliation: GCU
PICOT Question
According to a report by CDC, approximately 3 million people develop pressure injuries each year. Pressure ulcers reduce the quality of quality of life. Each year a considerably large number of people are diagnosed with pressure injuries. Various ways can be used to prevent the progression of this phenomenon. This paper evaluates the most effective option that can be applied to prevent pressure injuries. It is framed based on the PICOT statement,
(P) patients with severe pressure injuries.
(I) is the surgical removal of ulcers.
(C) compared with the administration of antibiotics.
(O) more effective in treatment of pressure injuries.
(T) in the short-term medical plan.
Edlich, R., Winters, K. L., Woodard, C. R., Buschbacher, R. M., Long III, W. B., Gebhart, J. H., & Ma, E. K. (2004). Pressure ulcer prevention. Journal of long-term effects of medical implants, 14(4).
This study explicitly analyzes prevention as well as treatment actions that should be taken by nurses who carry the burden of reducing this phenomenon. The study is a qualitative study, in the sense that it does not involve an analysis of data both mathematically and graphically.
The authors use published information to support their arguments hence it is a peer-reviewed secondary study.
After evaluation, the study confirms that nurses should conduct preventative measures to reduce the effects of pressure injuries. This can be achieved by involving various types of treatment and nursing interventions to mention a few.
Bluestein, D., & Javaheri, A. (2008). Pressure ulcers: prevention, evaluation, and management. American family physician, 78(10).
. This study comprehensively evaluates the predominant factors associated with wounds. The study relies on pre-existing data.
The authors conclude that appropriate dressing is important to prevent critical health issues. It is from this point of view that the study advises on thorough check-ups and in case there are no improvement medicals procedures should be taken.
Vanderwee, K., Defloor, T., Beeckman, D., Demarré, L., Verhaeghe, S., Van Durme, T., & Gobert, M. (2011). Assessing the adequacy of pressure ulcer prevention in hospitals: a nationwide prevalence survey. BMJ Quality & Safety, 20(3), 260-267.
The study assesses the efficacy of pressure ulcer prevention in health cares. This is a primary study because the author organizes, collect and analyzes data. Also, this is a quantitative study because it statistically analyzes data.
The study confirmed that there is a limited use of proper preventions measures with respect to pressure injuries and wounds. In other words, the study confirmed that there is a rather low-quality care.
Sving, E., Gunningberg, L., Högman, M., & Mamhidir, A. G. (2012). Registered nurses’ attention t ...
Patient Reported Outcomes (PRO) - Challenge and potential solutions.
Why and how can medical device and pharmaceutical companies, as well as the entire healthcare sector, leverage patient engagement with next-generation ePRO solutions?
Discover our white paper...
This document provides information about a session on urticaria diagnosis and management. The session objectives are to formulate an appropriate diagnostic workup for chronic urticaria considering differential diagnoses, and to incorporate evidence-based treatment guidelines. The session faculty are introduced and their qualifications and disclosures are provided. The document then reviews classification, pathophysiology, prevalence, and diagnostic evaluation of urticaria, including differential diagnoses. Specific urticaria subtypes like physical, autoimmune, and dermographic urticaria are also discussed.
The Impact of Patients’ Disease-Labels on Disease Experience Living Longer ...semualkaira
Advances in oncology have resulted in prolonged disease trajectories, also for patients with incurable cancer. This has induced discussions about the ‘right’ medical terminology. The impact of choosing a specific disease-label on well-being can be high.
The Impact of Patients’ Disease-Labels on Disease Experience Living Longer ...semualkaira
Advances in oncology have resulted in prolonged disease trajectories, also for patients with incurable cancer. This has induced discussions about the ‘right’ medical terminology. The impact of choosing a specific disease-label on well-being can be high.
The hospital is developing a nurse-run outpatient heart failure clinic to address high readmission rates for heart failure patients. The clinic aims to improve patient education, monitoring, and care coordination. The student has been asked to develop a plan for one component of the clinic - an orientation course plan, discharge education plan, or care coordination plan. The plan must be evidence-based, address patient needs, and indicate how effectiveness will be measured.
This document provides a summary of experience and qualifications for Mary Koppe-Dixon, RN. She has over 25 years of experience as a clinical research associate monitoring Phase I-IV trials across many therapeutic areas, including asthma, cardiology, neurology, and psychiatry. She is proficient in clinical trial management systems and has experience working with various electronic data capture systems. She holds a nursing license in Missouri and has managed clinical trial sites and coordinated clinical research operations.
1. SCOTT W. BAUMGARTNER, M.D.
Spokane, WA 99292 ∙ 858-736-1321 ∙ drswb49@hotmail.com
CLINICAL RESEARCH, EDUCATION, & MEDICAL AFFAIRS
PROFESSIONAL EXPERIENCE
drB CONSULTING, LLC CURRENT
OWNER & PRINCIPAL CONSULTANT
Providing consultation on numerous Healthcare issues. Clients include:
• Grunenthal GMBH, Aachen, Germany
• Ardea Biosciences, San Diego, CA
ARDEA BIOSCIENCES (A MEMBER OF THE ASTRA ZENECA GROUP) 2011 – JULY 2016
VICE PRESIDENT, MEDICAL AFFAIRS, (SEPTEMBER 2014 TO JULY 2016)
• Physician lead for Ardea /AstraZeneca Medical Affairs activities for gout franchise
• Physician Member on Global Brand and Payer Teams in support of a global launch
• Physician lead for publication planning
• Responsibilities/accountabilities for Medical Education, internal training, marketing company medical communications,
opinion leader interactions, professional society/organization support and interactions, strategy and planning
VICE PRESIDENT, CLINICAL RESEARCH & DEVELOPMENT (2013 TO 2014)
• Head of Clinical Development
o Member of Ardea Executive Management Team
o Accountability for management, budget development and approval, resourcing of Clinical Operations,
Biostatistics, Data Management functions (45 employees)
o Responsibility for clinical trial design and execution
o Involved in Business Development activities
• Global Brand Physician AstraZeneca
o Physician Member on Global Brand Team and Global Payer Team
o Physician Lead to AstraZeneca Global Medical Affairs
o Physician Lead for AstraZeneca Publication Planning
EXECUTIVE MEDICAL DIRECTOR, ARDEA BIOSCIENCES (2011 TO 2013)
• Medical Scientist on phase 3 clinical program
• Co-lead, Study Management Teams
• Medical input, review, and section authorship of clinical trial protocols, investigator brochure, regulatory documents
• Medical input to program strategy
• Co-developed Medical Affairs strategy, medical lead for publication planning, medical lead for advisory board
development and execution
AMGEN, INC. 2005-2011
MEDICAL DIRECTOR, GLOBAL CLINICAL DEVELOPMENT, INFLAMMATION, (GLOBAL DEVELOPMENT LEAD ENBREL RHEUMATOLOGY 2007-
2010, PHASE 2 DEVELOPMENT OF BRODALUMAB, 2009-2011)
Point of accountability for evidence generation and scientific communication
Develop and execute the global scientific/medical evidence plan
Provide medical and scientific input into key deliverables (e.g., regulatory filings and interactions, clinical study reports,
publications)
Oversee activities related to planning for studies
o Phase 2 program in 4 indications for brodalumab, an IL-17 inhibitor
o Phase 3 and 4 trials for Enbrel
Interpret and integrate the results of research programs (e.g. study data, competitor data, publications) into the overall
program strategy
Review and approve publication plan and publications
Perform due diligence for licensing proposals and support partner relationships
2. Present and defend budgets and resource requirements to Therapeutic Area Steering Committee
Present to review boards and upper management
Medical lead for interactions with regulatory agencies including End of Phase 2 meetings
Joint accountability with regulatory for Pediatric Investigational Plan for 4 indications
ASSOCIATE DIRECTOR, MEDICAL AFFAIRS, INFLAMMATION (2005-2007)
• Led the Medical Affairs Team for Enbrel Rheumatology
• Led development and execution of evidence generation activities
o Provided medical input into study-related documents (e.g. study concept documents and protocols, clinical study
reports)
o Medical monitor on clinical trials
o Lead or provided input to regional advisory boards
o Reviewed Investigator Sponsored Study (ISS) proposals and represented them at appropriate review boards
o Authored, reviewed and approved publication plan and publications
• Accountable for planning and developing relationships with academic and medical societies, Opinion Leaders, and
relevant professional organizations
• Provided medical input to the commercial Brand Planning process
• Medical Director responsible for input to Corporate Accounts and Access strategy and tactics
THE PHYSICIANS CLINIC OF SPOKANE 1995 – 2005
PRESIDENT OF THE BOARD, MEDICAL DIRECTOR
• President of Board of Directors of a Multi-specialty clinic
• With administrator prepared budgets and financial reports
• Lead strategic planning
• Lead mergers with 3 practices
• Responsible for recruiting new physicians
• Managed care and 3rd party payer negotiations
• Represented the clinic to external customers and public
MEDICAL DIRECTOR, CLINICAL RESEARCH CENTER
• Established research center which eventually employed 4 full time clinical coordinators and an administrative assistant.
• Prepared budget, tracked financials, represented clinic to sponsors
• Served as principal investigator or sub-investigator on over 100 clinical trials including phase 1 through 4
PRIVATE PRACTICE RHEUMATOLOGY
THE PHYSICIANS CLINIC OF SPOKANE, SPOKANE, WA, 1985 - 2005
ARTHRITIS ASSOCIATES OF COLORADO SPRINGS, COLORADO SPRINGS, CO, 1980 – 1985
MEDICAL LICENSURE
State of Washington
EDUCATION
Fellowship: Rheumatology University of Colorado Denver, CO1978 - 1980
Internal Medicine University of Colorado Denver, CO, 1976 - 1978
Residency: Internal Medicine Internship, University of Colorado Denver, CO, 1975 - 1976
Medical School: University of Washington School of Medicine, Seattle, WA1971 - 1975
Undergraduate: B.S. Biology - Magna cum Laude, Seattle University, Seattle, Washington1967 - 1971
ACADEMIC APPOINTMENTS
Faculty, Family Medicine Spokane, Residency Program, 1986 – 2005
Faculty, Internal Medicine Spokane Residency Program, 1986 – 2005
Clinical Assistant Professor of Medicine, Rheumatology, University of Washington, 1986 - 2005
Clinical Assistant Professor of Medicine, Rheumatology, University of Colorado, 1983 - 1985
BOARD CERTIFICATIONS
Association of Clinical Research Professionals, Nov. 8, 2002
American Board of Internal Medicine, Subspecialty Rheumatology, June 17, 1980
American Board of Internal Medicine, Sept 13, 1978
3. National Board of Medical Examiners, 1976
Certified Clinical Research Investigator
MEMBERSHIPS & ACTIVITIES
Washington State Medical Association, 1985-2005
Spokane County Medical Society, 1985-2005
Spokane Society of Internal Medicine, 1986-2005
American College of Physicians/ASIM, Member, 1980-2005
American College of Rheumatology, Fellow, 1980
Alpha Omega Alpha, 1975
PUBLICATIONS, MANUSCRIPTS
Lewis, TL, Lain D, Baumgartner, SW, “Comparison of Diflunisal and Piroxicam in the Management of Patients with Osteoarthritis’,
Clinical Therapies, Vol. 9, Suppl. C., 1986
Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, Ettlinger RE, Cohen S, Koopman WJ, Mohler K,
Widmer MB, Blosch CM: Treatment of Rheumatoid Arthritis With a Recombinant Human Tumor Necrosis Factor Receptor (p75)-fc
Fusion Protein. New England Journal of Medicine 337:146, 1997
Moreland LW, Schiff MH, Baumgartner SW, Tindall EA, Fleischmann RM, Bulpitt KJ, Weaver AL, Keystone EC, Furst DE, Mease PJ,
Ruderman EM, Blosch CM, Lange MLM, McDonnell ND, Weinblatt ME: Etancercept Therapy in Rheumatoid Arthritis, A
Randomized, Controlled Trial, Ann Internal Med. 1999; 130:478-486
Baumgartner SW, Tumor Necrosis Factor Inactivation in the Management of Rheumatoid Arthritis, Southern Medical Journal
2000;93(8): 753-759
Larry W. Moreland, Stanley B. Cohen, Scott W. Baumgartner, Elizabeth A. Tindall, Ken Bulpitt, Richard Martin, Michael Weinblatt,
James Taborn, Arthur Weaver, Daniel J Burge, Michael H. Schiff, Long-term Safety and Efficacy of Etanercept in Patients with
Rheumatoid Arthritis, The Journal of Rheumatology 2001; 28:6
Roy M. Fleischmann, Scott W. Baumgartner, Elizabeth A. Tindall, Arthur L. Weaver, Larry W. Moreland, Michael H. Schiff, Richared
W. Martin, and George T. Spencer-Green, Response to Etanercept (Enbrel®) in Elderly Patients with Rheumatoid Arthritis: A
Retrospective Analysis of Clinical Trial Results, The Journal of Rheumatology 2003; 30:4
Baumgartner SW, Fleischmann RM, Moreland LW, Schiff MH, Markenson J, Whitmore JB: Etanercept (Enbrel) in Patients with
Rheumatoid Arthritis with Recent Onset Versus Established Disease: Improvement in disability, Journal of Rheumatology, Vol 31,
No. 8, 1532-1537, 2004
Mease PJ, Ritchlin CT, Martin RW, Gottlieb AB, Baumgartner SW, Burge DJ, Whitmore JB: Pneumococcal Vaccine Response in
Psoriatic Arthritis Patients During Treatment with Etanercept, Journal of Rheumatology, Vol. 31, No. 7, 1356-1361, 2004
Fleischmann R, Baumgartner SW, Weisman MH, Liu T, White B, Peloso P, Long- term safety of etanercept in elderly patients with
rheumatic diseases, Annals of Rheumatic Diseases 2006;65: 379-384.
Inman R, Clegg D, Davis JC, Whitmore JB, Solinger A, Baumgartner S, Etanercept in adult patients with early onset ankylosing
spondylitis, J Rheum 2006;33(8):1634-1636.
Weisman M, Paulus H, Burch F, Kivitz A, Fierer J, Dunn M, Kerr D, Tsuji W, Baumgartner S, A placebo-controlled, randomized,
double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid
diseases Rheumatology 2007 Jul;46(7):1122-5.
Bingham CO, Ince A, Haraoui B, Keystone EC, Chon Y, Baumgartner S, Effectiveness and safety of etanercept in subjects with RA
who have failed infliximab therapy: 16-week, open-label observational study, Current Medical Research and Opinion, 25(5), 2009,
1131-1142
4. Sokolove J, Strand V, Greenberg JD, Curtis JR, Kavanaugh A, Kremer JM, Anofrei A, Reed G, Calabrese L, Hooper M, Baumgartner S,
Furst DE, Risk of elevated liver enzymes associated with TNF inhibitor utilization in patients with rheumatoid arthritis, Ann Rheum
Dis 2010; 69: 1612-1617
Lovell D, Wallace C, Ilowite N, Reiff A, Chon Y, Baumgartner S, Giannini E, Safety of up to 8 years of continuous etanercept therapy
in patients with juvenile rheumatoid arthritis, Arthritis Rheum 2008; 58(5): 1496-1504
E. H. Giannini, N. T. Ilowite, D. J. Lovell, C. A. Wallace, C. E. Rabinovich, A. Reiff,
G. Higgins, B. Gottlieb, N. G. Singer, for the Pediatric Rheumatology Collaborative Study
Group, Y. Chon, S.-L. Lin, and S. W. Baumgartner, Long-Term Safety and Effectiveness of Etanercept in Children with Selected
Categories of Juvenile Idiopathic Arthritis, Arthritis Rheum 2009; 60 (9); 2794-2804
Joachim Sieper, Andy Koenig, Scott Baumgartner, Carole Wishneski, Joanne Foehl, Bonnie Vlahos, Bruce Freundlich, Analysis of
uveitis rates across all etanercept ankylosing spondylitis clinical trials, Ann Rheum Dis 2010;69:226–229
Weinblatt ME, Keystone EC, Cohen MD, Freundlich B, Li J, Chon Y, Baumgartner S, Predictors of radiographic progression in
rheumatoid arthritis patients treated with methotrexate, J Rheum 2011; 38:2;242-246
ME Weinblatt, JM Bathon, JM Kremer, RM Fleischmann, MH Schiff, RW Martin, SW Baumgartner, GS Park, EL Mancini, MC
Genovese, Safety and efficacy of Etanercept Beyond 10 Years of Therapy in North American Patients with Early and Long-Standing
Rheumatoid Arthritis, Arthritis Care & Research 63(3) 2011, 373-382
Edward H. Giannini DrPH, MSc1,*,†, Norman T. Ilowite MD2, Daniel J. Lovell MD, MPH1, Carol A. Wallace MD3, C. Egla Rabinovich
MD4, Andreas Reiff MD5, Gloria Higgins PhD, MD6, Beth Gottlieb MD, MS7, Yun Chon PhD8, Nan Zhang PhD8, Scott W.
Baumgartner MD8 Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic
arthritis, Arthritis & Rheumatism 2010, 62:11, 3229-3264
Gibofsky A, Palmer WR, Keystone EC, Schiff MH, Feng J, McCroskery P, Baumgartner S, Markenson JA, Rheumatoid Arthritis
Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Studies; Safety and Etanercept Utilization Analyses from the
RADIUS 1 and RADIUS 2 Registries, J Rheum 2011; 38:1; 1-8
Alice B. Gottlieb MD PhD, Kenneth Gordon MD, Edward H. Giannini MSc DrPH, Philip Mease MD, Juan Li PhD, Yun Chon PhD, Judy
Maddox DO, Haoling H. Weng MD MHS, Joseph Wajdula PhD, Shao-Lee Lin MD PhD, Scott W. Baumgartner MD, Clinical Trial
Safety and Mortality Analysis in Patients Receiving Etanercept Across Approved Indications, Journal of Drugs in Dermatology 2011;
10 (3): 289-300
Markenson JA, Gibofsky A, Palmer WR, Keystone EC, Schiff MH, Feng J, Baumgartner SW, Persistence with Anti-Tumor Necrosis
Factor Therapies in Patients with Rheumatoid Arthritis: Observations from the RADIUS Registry, J Rheum 2011; 38:7;
doi.10.3800/jrheum.101142 (Early Release May 15, 2011)
David M. Pariser, MD; Craig L. Leonardi, MD; Kenneth Gordon, MD; Alice B. Gottlieb, MD, PhD; Stephen Tyring, MD, PhD; Kim A.
Papp, MD; Joanne Li, PhD; Scott W. Baumgartner, MD, Integrated Safety Analysis: Short- and Long-Term Safety Profiles of
Etanercept in Patients with Psoriasis, In Press, Journal of the American Academy of Dermatology, doi: 10.1016/j.jaad.2011.07.040
Jie Zhang PhD, Ying Shan MD MPH, George Reed PhD, Joel Kremer MD, Jeffrey Greenberg MD, Scott Baumgartner, MD, Jeffrey R
Curtis MD MS MPH, Thresholds in Disease Activity for Switching Biologics in RA Patients, Arthritis Care & Research, 63(12), 1672-
1679, 2011
Varni JW, Globe DR, Gandra SR, Harrison DJ, Hooper M, Baumgartner S, Health-related quality of life of pediatric patients with
moderate to severe plaque psoriasis: comparisons to four common chronic diseases, European Journal of Pediatrics 171:485-492,
2012
Mandema JW, Salinger DH, Baumgartner SW, Gibbs MA, A Dose-Response Meta-Analysis for Quantifying Relative Efficacy of
Biologics in Rheumatoid Arthritis, Clinical Pharmacology & Therapeutics, 90;6: 828-835, 2011
Papp KA, Leonardi C, Menter A, Ortonne J, Krueger JG, Krikorian G, Aras G, Li J, Russell CB, Thompson EHZ, Baumgartner S,
Brodalumab, an Anti-Interleukin-17-Receptor Antibody for Psoriasis, New England Journal of Medicine, 355;13: 1181-1189, 1012
5. Fleischmann R, Kerr B, Yeh L, Suster M, Shen Z, Polvent E, Hingorani V, Quart B, Manhard K, Miner J, Baumgartner S,
Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of Lesinurad and febuxostat in gout
patients with hyperuricaemia, Rheumatology Advance Access published February 8, 2014, doi:10.1093/rheumatology/ket487
Khanna P, Khanna D, Storgard C, Baumgartner S, Morlock R, A world of hurt: failure to achieve treatment goals in patients with
gout requires a paradigm shift, Postgraduate Medicine 2015; Early Online 1-7, DOI:10.1080/00325481.2016. 1113840
An open-label, 6-month study of allopurinol safety in gout: The LASSO study, Becker M, Fitzpatrick D, Choi H, Dalbeth N, Storgard
C, Cravets M, Baumgartner, S, Seminars in Arthritis and Rheumatism 2015; open access dx.coi.org/10.1016/jsemarthrit.
2015.05.005
Doghramji P, Fermer S, Wood R, Morlock R, Baumgartner S. Management of gout in the real world: current practice versus
guideline recommendations. Postgrad Med. 2016 Jan; 128(1):106-14. doi: 10.1080/00325481.2016.1114878. Epub 2015 Nov 23
PUBLICATIONS, ABSTRACTS
Baumgartner SW, Moreland LW, Schiff MH, Tindall E, Fleischmann R, Weaver AL,Ettlinger R, Gruber BL, Katz RS, Skosey JL, Lies RB,
Robinson A, Blosch CM: “Double-blind, Placebo-controlled Trial of Tumor Necrosis Factor Receptor (p80) Fusion Protein (TNFR:fc)
in Active Rheumatoid Arthritis”. Arthritis and Rheumatism, 39; 9 (suppl): S74, 1996.
Baumgartner SW, Moreland LW, et al.: Phase III and long-term treatment of DMARD failing rheumatoid arthritis patients with TNF
receptor p75 fc fusion protein. Presented at EULAR ’97, Vienna Austria 1997.
Moreland LW, Baumgartner SW, Schiff MH et al.: Optimal dose of TNF receptor P75 fusion prtoein. Arthritis and Rheumatism, Vol.
41, N0. 9, 1998
Baumgartner SW, Moreland LW, Schiff MH, et al.: Response of elderly patients to TNF receptor P75 fusion protein. Arthritis and
Rheumatism, Vol. 41, 1998
Baumgartner SW, Morelend LW, Schiff MH, Tindall E, Fleischmann RM, Weaver A, Ettlinger RE, Gruber BL, Katz RS, Skosey JL, Lies
RB, Robinson A, Blosch C: Double-blind, placebo controlled trial of tumor necrosis factor receptor fusion protein (TNFR:fc) in active
rheumatoid arthritis (abstract), J Invest Med 44:23A, 1996
Baumgartner SW, Fleischmann RM, Moreland LW, Schiff MH, Markenson J, Spencer-Green GT: Improvement in Disability in RA
Patients with Early vs Established Disease treated with Enbrel, (abstract), Arthritis and Rheumatisms, Vol 43, No. 9 (suppl), S230,
2000.
Moreland LM, Cohen SB, Baumgartner SW, Schiff MH, Tindall EA, Bukpitt K, Burge DJ: Long-Term Use of Enbrel in Patients with
DMARD-Refractory Rheumatoid Arthritis (abstract), Arthritis and Rheumatism, Vol 43, No. 9 (suppl), S270, 2000
Klareskog L, Moreland LW, Cohen SB, Baumgartner SW, Tindall EA, Kalden JR, Whitmore JB, Tsuji WH, The safety and efficacy of
over seven years of continuous etanercept therapy in patients with rheumatoid arthritis in North America and Europe
2005;64(suppl III):410. Abstract #SAT0006.
Klareskog L, Moreland LW, Cohen SB, Kalden , JR, Wajdula J, Chon Y, Baumgartner SW, Tsuji WH (Abstract) Safety and efficacy of
over eight years of continuous etanercept therapy in patients with rheumatoid arthritis in North America and Europe, EULAR 2006
Kremer JM, Reed G, White B, Baumgartner, Lin S-L, An analysis of risk factors and effect of treatment on the development of
cardiovascular disease in patients with rheumatoid arthritis, EULAR 2006
Greenberg, Lin S, Dektor D, Baumgartner S, Chi E, White B, Dabbous O, Montgomery M, Hinkle K, Reed G, Abramson S, Kremer J
(Abstract) Association of duration of TNF antagonist treatment with reduction in cardiovascular outcomes in RA patients, ACR
2006
6. Weinblatt M, Keystone E, Cohen M, Baumgartner S, Freundlich B, Li J, Chon Y, Predictors of poor radiographic response in
rheumatoid arthritis subjects treated with methotrexate: Preliminary analysis from the ERA and TEMPO studies (Abstract)
2006;54:S181-S182.327
Gu N, Huang X, Patel V, Baumgartner S, Fox K, and Chiou CF (Abstract) Assessing dosing patterns of TNF antagonists and associated
costs for rheumatoid arthritis patients treated in routine clinical practice, Association of Managed Care Pharmacists 2007
Klareskog L, Moreland LW, Cohen SB, Kalden JR, Wajdula J, Chon Y, Lin S-L, Baumgartner SW (Abstract) Safety and efficacy of over
9 years of continuous etanercept therapy in patients with rheumatoid arthritis in North America and Europe, Annals of
Rheujmatic Disease, 2007;66:177. THU0170
Engel-Nitz NM, Huang X, Globe D, Baumgartner S, Dosing patterns and costs of adalimumab, etanercept, and infliximab among
patients with rheumatoid arthritis, EULAR 2007
Lovell D, Giannin E, Wallace C, Ilowite N, Reiff A, Chon Y, Lin S-L, Baumgartner S, Safety of over 8 years of continuous etanercept
therapy in patients with juvenile rheumatoid arthritis, Annals of Rheumatic Disease 2007;66:112. OP0191
Kim Papp Craig Leonardi, Alan Menter, Jean-Paul Ortonne, Gregory Kricorian, Juan Li, Elizabeth Thompson, Scott Baumgartner,
Efficacy and Safety of AMG 827 in Patients with Moderate to Severe Plaque Psoriasis: Results of a Phase 2, Randomized, Double-
blind, Placebo-controlled Study, Abstract number FC22-02, accepted as oral presentation World Congress of Dermatology, May
2011
Kim Papp, Craig Leonardi, Alan Menter, Jean-Paul Ortonne, Scott Baumgartner, Elizabeth HZ Thompson, Brian Ortmeier, Girish
Aras, Gregory Kricorian, Health-Related Quality of Life in Subjects Undergoing Therapy With AMG 827 For Moderate to Severe
Plaque Psoriasis, European Academy of Dermatology and Venereology, Lisbon, Portugal; October 20-24, 2011 Poster PO1094
Baumgartner S, Choi H, Dalbeth N, Fitzpatrick D, Cravets M, Storgard C, Allopurinol Dose Titratioin and Efficacy: A Large-Scale,
International, 6 Month, Multicenter, Prospective Study, Arthritis Rheum 2013: 65 (Suppl): S503
Singh J, Storgard C, Baumgartner S, Morlock R, High-dose allopurinol in France, Germany, Italy, Spain, and the United Kingdom,
Ann Rheum Dis 2013;72(Suppl3):713
Khanna P, Khanna D, Storgard C, Baumgartner S, Morlock R, Assessing Serum Uric Acid (sUA) Levels, Flare Rates, and Tophi in
Patients with Gout Treated with Xanthine Oxidase (XO) Inhibitors in the United Sates, Ann Rheum Dis 2013;72(Suppl3):770
Khanna P, Khanna D, Storgard C, Baumgartner S, Morlock R, Patients Who Flare Despite Reaching EULAR/ACR-recommended
Serum Urate Target, Ann Rheum Dis 2013;72(Suppl3):713
Becker M, Fitzpatrick D, Storgard C, Cravets M, Baumgartner S, A Large-Scale, Multicenter, Prospective, Open Label, 6-Month Study
to Evaluate the Safety of allopurinol Monotherapy in Patients with Gout, Arthritis Rheum 2013;65(Suppl): S502
Khanna P, Khanna D, Storgard C, Baumgartner S, Morlock R, More Than One-Third of Patients Reach Serum Urate Target and
Continue to Report Multiple Flares, Arthritis Rheum 2013;65(Suppl):S501
Morlock R, Baumgartner S, Storgard C, Use of High-Dose Allopurinol to Reach Serum Uric Acid Targets in Patients With Gout Across
Multiple Countries, Arthritis Rheum 2013;65(Suppl):S502
Wood R, Johnson J, Morlock R, Baumgartner S, Ramachandran S, Gout Patients Treated with Conventional Urate Lowering
Therapy: Association Between Disease Control and Work Productivity, EULAR 2014, Abstract H3532
Wood R, Johnson J, Morlock R, Baumgartner S, Ramachandran S, Gout Patients Treated with Conventional Urate Lowering
Therapy: Association Between Disease Control and Health-Related Quality of Life, EULAR 2014, Abstract H3531
Dalbeth N, Jones G, Terkeltaub R, Khanna D, Kopicko J, Adler S, Bhakta N, Fung M, Storgard C, Baumgartner S, Perez-Ruiz F,
Lesinurad and Febuxostat Combination Therapy: Analysis of Treatment Based on Patient Baseline Renal Function, American
College of Rheumatology, San Francisco 2015
7. Dalbeth N, Jones G, Terkeltaub R, Khanna D, Kopicko J, Adler S, Bhakta N, Fung M, Storgard C, Baumgartner S, Perez-Ruiz F, Efficacy
and Safety in Patients With Tophaceous Gout Receiving Lesinurad and Febuxostat Combination Therapy: Interim Analysis of an
Extension Study, American College of Rheumatology San Francisco 2015
Terkeltaub R, Perez-Ruiz F, Kopicko J, Fung M, Bhakta N, Adler S, Storgard C, Baumgartner S, Dalbeth N, The Safety and Efficacy of
Lower Serum Urate Levels: a Pooled Analysis of Gout Subjects Receiving Lesinurad and Xanthine Oxidase Inhibitors, American
College of Rheumatology, San Francisco 2015
Dalbeth N, Jones G, Terkeltaub R, Khanna D, Kopicko J, Bhakta N, Fung M, Storgard C, Baumgartner S, Perez-Ruiz F, Lesinurad, a
Novel Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat, in Patients With Tophaceous Gout, American
College of Rheumatology, San Francisco 2015
Saag K, Bardin T, So A, Khanna P, Storgard C, Baumgartner S, Fung M, Bhakta N, Adler S, Kopicko J, Becker M, Analysis of Gout
Subjects Receiving Lesinurad and Allopurinol Combination Therapy by Baseline Renal Function , American College of Rheumatology
San Francisco 2015
Perreault S, Nuevo J, Baumgartner S, Morlock R, Gout Control Among Hypertensive Patients With Gout and the Relationship to
Onset of End-stage Renal Disease, International Congress of Pharmicoepidemiology and Therapeutic Risk management (ICPE),
Boston 2015
Perreault S, Nuevo J, Baumgartner S, Morlock R, Adherence and Persistence to Allopurinol Among Hypertensive Patients with
Gout, ICPE, Boston 2015